
Well Lead Medical Co., Ltd.
SSE:603309.SS
12.41 (CNY) • At close June 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,509.335 | 1,371.926 | 1,363.353 | 1,118.571 | 1,130.679 | 993.813 | 745.835 | 629.895 | 515.42 | 548.871 | 496.414 | 437.167 | 387.221 | 348.235 |
Cost of Revenue
| 837.189 | 750.921 | 774.497 | 644.731 | 635.953 | 554.094 | 483.535 | 414.8 | 322.647 | 365.404 | 317.549 | 277.345 | 250.021 | 236.282 |
Gross Profit
| 672.146 | 621.004 | 588.855 | 473.84 | 494.726 | 439.719 | 262.299 | 215.095 | 192.773 | 183.467 | 178.865 | 159.822 | 137.199 | 111.953 |
Gross Profit Ratio
| 0.445 | 0.453 | 0.432 | 0.424 | 0.438 | 0.442 | 0.352 | 0.341 | 0.374 | 0.334 | 0.36 | 0.366 | 0.354 | 0.321 |
Reseach & Development Expenses
| 111.112 | 94.922 | 82.074 | 55.026 | 55.31 | 42.251 | 16.739 | 12.001 | 9.721 | 5.701 | 4.579 | 2.515 | 0.802 | 0 |
General & Administrative Expenses
| 35.532 | 38.55 | 27.19 | 26.428 | 22.947 | 25.749 | 25.244 | 18.106 | 15.451 | 15.625 | 9.935 | 10.396 | 9.41 | 29.313 |
Selling & Marketing Expenses
| 66.982 | 61.546 | 156.024 | 142.944 | 97.239 | 123.145 | 74.041 | 53.381 | 46.805 | 36.82 | 30.454 | 27.774 | 26.941 | 18.338 |
SG&A
| 102.514 | 292.85 | 183.214 | 169.372 | 120.187 | 148.894 | 99.285 | 71.487 | 62.257 | 52.444 | 40.388 | 38.17 | 36.351 | 47.651 |
Other Expenses
| 193.021 | -1.512 | 107.99 | 88.59 | 88.145 | 86.971 | -1.025 | 0.394 | 10.266 | 3.398 | 0.991 | 1.437 | 2.336 | 0.153 |
Operating Expenses
| 406.647 | 386.259 | 373.277 | 312.988 | 263.642 | 278.117 | 195.273 | 139.724 | 123.879 | 104.212 | 87.212 | 77.925 | 66.846 | 51.247 |
Operating Income
| 265.499 | 238.839 | 206.653 | 142.719 | 198.267 | 146.85 | 69.628 | 72.338 | 85.252 | 97.37 | 86.147 | 76.68 | 65.728 | 58.802 |
Operating Income Ratio
| 0.176 | 0.174 | 0.152 | 0.128 | 0.175 | 0.148 | 0.093 | 0.115 | 0.165 | 0.177 | 0.174 | 0.175 | 0.17 | 0.169 |
Total Other Income Expenses Net
| -2.456 | -1.536 | -1 | -2.496 | -8.156 | 0.882 | -1.025 | 0.394 | 10.046 | 3.224 | 0.964 | 1.278 | -0.681 | 0.145 |
Income Before Tax
| 263.044 | 237.303 | 205.653 | 140.224 | 190.112 | 147.732 | 68.603 | 72.732 | 95.211 | 100.595 | 87.111 | 77.958 | 68.034 | 58.948 |
Income Before Tax Ratio
| 0.174 | 0.173 | 0.151 | 0.125 | 0.168 | 0.149 | 0.092 | 0.115 | 0.185 | 0.183 | 0.175 | 0.178 | 0.176 | 0.169 |
Income Tax Expense
| 34.572 | 32.7 | 27.9 | 25.549 | 30.232 | 23.242 | 12.16 | 12.47 | 16.548 | 9.272 | 19.297 | 14.456 | 12.772 | 9.595 |
Net Income
| 219.393 | 192.485 | 166.571 | 106.093 | 153.111 | 121.145 | 65.403 | 64.557 | 79.25 | 91.325 | 67.82 | 63.586 | 55.609 | 47.925 |
Net Income Ratio
| 0.145 | 0.14 | 0.122 | 0.095 | 0.135 | 0.122 | 0.088 | 0.102 | 0.154 | 0.166 | 0.137 | 0.145 | 0.144 | 0.138 |
EPS
| 0.75 | 0.66 | 0.58 | 0.41 | 0.59 | 0.47 | 0.25 | 0.25 | 0.31 | 0.37 | 0.35 | 0.33 | 0.28 | 0.25 |
EPS Diluted
| 0.75 | 0.66 | 0.58 | 0.41 | 0.59 | 0.47 | 0.25 | 0.25 | 0.31 | 0.37 | 0.35 | 0.33 | 0.28 | 0.25 |
EBITDA
| 347.749 | 317.194 | 285.145 | 204.555 | 250.785 | 206.966 | 105.77 | 97.328 | 114.602 | 118.779 | 105.386 | 91.287 | 79.44 | 60.705 |
EBITDA Ratio
| 0.23 | 0.231 | 0.209 | 0.183 | 0.222 | 0.208 | 0.142 | 0.155 | 0.222 | 0.216 | 0.212 | 0.209 | 0.205 | 0.174 |